Detalhe da pesquisa
1.
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials.
Blood
; 133(10): 1020-1030, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30404811
2.
Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.
J Intern Med
; 281(3): 284-299, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926979
3.
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upâ.
Ann Oncol
; 32(2): 142-156, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221366
4.
Identification of clonal skin myeloid cells by next-generation sequencing in myelodysplasia cutis.
Br J Dermatol
; 184(2): 367-369, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32964412
5.
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
Ann Hematol
; 92(5): 621-31, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23358617
6.
[Behçet's-like syndrome and other dysimmunitary manifestations related to myelodysplastic syndromes with trisomy 8]. / Syndrome de pseudo-Behçet et autres manifestations dysimmunitaires associées aux syndromes myélodysplasiques avec trisomie 8.
Rev Med Interne
; 42(3): 170-176, 2021 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-33139078
7.
Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.
Leuk Lymphoma
; 62(2): 438-445, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33043739
8.
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 25 Suppl 3: iii57-69, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25185242
9.
Occupational exposure to pesticides and lymphoid neoplasms among men: results of a French case-control study.
Occup Environ Med
; 66(5): 291-8, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19017688
10.
[Extramedullary blastic transformation revealed by a prolonged fever during the course of a 5q- syndrome]. / Fièvre prolongée au cours d'un syndrome 5q- révélant une transformation blastique extramédullaire.
Rev Med Interne
; 30(10): 886-9, 2009 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-19748163
11.
[Management of myelodysplastic syndromes in 2019: An update]. / Prise en charge des syndromes myélodysplasiques en 2019 : mise au point.
Rev Med Interne
; 40(9): 581-589, 2019 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-31054780
12.
Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Oncogene
; 26(16): 2299-307, 2007 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17043643
13.
NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Oncogene
; 26(28): 4071-83, 2007 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-17213804
14.
Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study.
Cancer Causes Control
; 19(10): 1147-60, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18781390
15.
Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide.
Leuk Res
; 32(7): 1049-53, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18191202
16.
Treatment of acute promyelocytic leukemia by retinoids.
Curr Top Microbiol Immunol
; 313: 101-28, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17217041
17.
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.
Leukemia
; 21(9): 1907-14, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17611565
18.
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
Leukemia
; 21(3): 453-61, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17252021
19.
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.
Leuk Res
; 71: 67-74, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025278
20.
The IPSS-R has prognostic impact in untreated patients with MDS del(5q).
Leuk Res
; 72: 27-33, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30075323